Molecule Information
General Information of the Molecule (ID: Mol02045)
| Name |
Beta-lactamase (Q6QJ55)
,Pseudomonas aeruginosa
|
||||
|---|---|---|---|---|---|
| Synonyms |
blaoxa-10; bla1; blaOXA-10; OXA-10; oxa-10; oxa10; E5D53_33915; GUL26_37150; PA52Ts2_0147
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
Q6QJ55
|
||||
| Sequence |
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD IDNESKLPLRKSIPTKIMESEGIIGG Click to Show/Hide
|
||||
| 3D-structure |
|
||||
| Uniprot ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Carbapenem-nonsusceptible Pseudomonas aeruginosa infection [ICD-11: 1A00-1C4Z] | [1] | |||
| Resistant Disease | Carbapenem-nonsusceptible Pseudomonas aeruginosa infection [ICD-11: 1A00-1C4Z] | |||
| Resistant Drug | Tazobactam | |||
| Molecule Alteration | Function | Inhibition |
||
| Experimental Note | Discovered Using In-vivo Testing Model | |||
| In Vitro Model | Carbapenem-nonsusceptible Pseudomonas aeruginosa strain | 287 | ||
| Experiment for Molecule Alteration |
Whole-genome sequencing assay | |||
| Mechanism Description | Ceftolozane/tazobactam (C/T), a novel beta-lactam/beta-lactamase inhibitor combination, addresses an unmet medical need in patients with these multidrug-resistant P. aeruginosa infections. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
